PubMed · 7910316
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
1994-05-28. City limits.. https://pubmed.ncbi.nlm.nih.gov/7910316/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Explore the source record for details and available documents.
Environmental tobacco smoke (ETS) is a major source for indoor air pollution. Although ETS-caused indoor air pollution has been well studied in the developed countries, few studies have examined ETS indoor air pollution in China, which currently has the largest population of tobacco smokers. In this study, respirable-particulate (RP) from ETS-contaminated (RP-ETS) indoor air was collected and measured in 5 different indoor environments during the winter in the northwestern Liaoning Province, China. The extractable portion of RP-ETS (ERP-ETS) was obtained by dichloromethane extraction and used in the Salmonella mutagenicity assay in the presence of S9 using strains TA98, TA100, and TA1538. The percentage of RP-ETS attributable to ETS (ETS-RP) and the percentage of ERP-ETS attributable to ETS (ETS-ERP) were estimated by measuring the concentration of solanesol, an ETS marker. Comparative results in 5 different indoor environments were: (1) the concentration of RP-ETS ranged from 197.3 to 1227.6 microg/m(3) and approximately 64.7 to 92. 0% of the RP-ETS originated from ETS; (2) the concentration of ERP-ETS ranged 88.8 to 601.5 microg/m(3) and approximately 83.1 to 95.4% of the ERP-ETS originated from ETS; (3) the mutagenic potency (revertants/m(3)) of ERP-ETS ranged from 60.4 to 595.5 for TA98, from 33.7 to 312.8 for TA100, and from 49.7 to 475.2 for TA1538. The data indicate that the extent of ETS pollution and the potential health hazards of ETS to humans in the five indoor environments are in the following increasing order: rural bedrooms, urban living rooms, office rooms, restaurants, and passenger cars in that area.
The critical components of clean-room and barrier isolator systems are described. Cleanroom and barrier isolator systems have four basic parts: the physical structure, the internal environment, the interaction technology, and the monitoring system. To create an aseptic environment, pharmacists must understand each of these components and be able to provide vendors with clear specifications. Among the decisions pharmacists must make are what materials should be used in construction, how many filters to use and where these should be placed, how to best reduce the contamination challenge to the area, and the best means of monitoring the room's air cleanliness. Evaluation of each component should be made on the basis of durability, functionality, and cost. Pharmacists must also have a set of criteria to help them choose a vendor. They must know their state's requirements and ensure that whatever system is built for their organization will meet all regulations. Cleanroom and barrier isolator systems must adhere to Federal Standard 209E, which defines standard classes of air cleanliness that are based on specific concentrations and sizes of airborne particles. Having an understanding of the basic components of cleanroom and barrier isolator systems will help pharmacists define their needs and describe them to vendors.